肝肉瘤样癌在计算机断层扫描与钆塞酸增强磁共振成像上的影像学特征
研究纳入24例病理证实的肝肉瘤样癌患者(含肉瘤样肝内胆管癌13例、肉瘤样肝细胞癌7例等),评估CT和钆塞酸增强MRI的形态、信号及强化特征。结果显示肿瘤多呈分叶状轮廓,肉瘤样肝内胆管癌多表现为弱强化或初始薄环状强化,T2高信号区常见,且血管侵犯和复发进展频率高。
要点
- 肝肉瘤样癌多呈分叶状轮廓,动脉期常表现为轻微环状强化或极度乏血供。
- 肉瘤样肝内胆管癌多表现为弱强化或初始薄环状强化,肉瘤样肝细胞癌及其他类型多呈薄或厚强化模式。
- T2高信号区常见,反映广泛坏死;血管侵犯和术后复发进展频率高。
核心结论
- 肝肉瘤样癌包括肉瘤样肝细胞癌和肉瘤样肝内胆管癌,在CT和钆塞酸增强MRI上通常表现为轻微环状动脉强化或极度乏血供,并因广泛坏死和血管侵犯而常见T2高信号区。
研究设计与样本
- 研究纳入24例病理证实的肝肉瘤样癌患者(肉瘤样肝内胆管癌13例、肉瘤样肝细胞癌7例、肉瘤样癌2例、癌肉瘤1例、肉瘤样混合型肝细胞-胆管癌1例),肿瘤大小范围2.1-23 cm(平均8.3 cm);20例行钆塞酸增强MRI,24例行动态CT;17例有慢性肝炎或肝硬化背景;两名阅片者基于共识评估肿瘤形态、信号强度和强化特征。
关键影像表现/征象
- 15个肿瘤(62.5%)呈分叶状轮廓,其余为圆形或卵圆形肿块;肉瘤样肝内胆管癌在CT(10例)和MRI(7例)上表现为弱强化,或在CT(3例)和MRI(6例)上表现为初始薄环状强化伴或不伴渐进性强化;肉瘤样肝细胞癌及其他4个肿瘤在CT和MRI上均表现为薄或厚强化模式;10个肿瘤T2呈类似液体的高信号;2例肉瘤样肝内胆管癌和2例肉瘤样肝细胞癌在肝胆期和扩散加权成像上可见靶征。
临床应用与阅片要点
- 阅片时应注意肝肉瘤样癌可表现为分叶状轮廓、动脉期轻微环状强化或极度乏血供,以及T2高信号区(提示坏死);肝胆期和扩散加权成像上的靶征可见于肉瘤样肝内胆管癌和肉瘤样肝细胞癌;组织学上18例手术切除肿瘤中17例有血管侵犯和/或血栓形成,而CT和MRI仅显示12例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine the imaging features of hepatic sarcomatous carcinoma including sarcomatous intrahepatic cholangiocarcinoma (S-ICC) and sarcomatous hepatocellular carcinoma (S-HCC) on computed tomography (CT) and gadoxetic acid-enhanced magnetic resonance imaging (MRI).
MATERIALS AND METHODS: Twenty-four patients with pathologically confirmed S-ICCs (n = 13), S-HCCs (n = 7), sarcomatous carcinoma (n = 2), carcinosarcoma (n = 1), and sarcomatous combined HCC-CC (n = 1) (size range 2.1-23 cm, mean 8.3 cm) underwent gadoxetic acid-enhanced MRI (n = 20) and/or dynamic CT (N = 24). Underlying chronic hepatitis or cirrhosis was found in 17 patients. Two reviewers evaluated morphology, signal intensity, and enhancement features of tumors based on a consensus.
RESULTS: Lobulated contour was observed in 15 tumors (62.5%); the rest were round or oval masses. During dynamic imaging, S-ICCs showed poor enhancement (n = 10 on CT; n = 7 on MRI) or initial thin-rim enhancement with/without progressive enhancement (n = 3 on CT; n = 6 on MRI). S-HCCs and the other four tumors showed a thin or thick enhancement pattern on both CT and MRI. T2 bright signal intensity similar to fluid was found in 10 tumors. Target appearance on hepatobiliary phase and diffusion-weighted imaging was seen in two S-ICCs and two S-HCCs. Of 18 surgically resected tumors, 17 showed vascular invasion and/or thrombosis in histology and 12 in CT and MRI. Ten tumors were accompanied by intrahepatic metastasis or tumor seeding and 19 patients had recurrence or progression of tumors during follow-up.
CONCLUSION: Hepatic sarcomatous carcinoma including S-HCC and S-ICC generally presents minimal rim-like arterial enhancement or extreme hypovascularity on CT and gadoxetic acid-enhanced MRI with a high frequency of T2 bright area due to extensive necrosis and vascular invasion.
引用
- Gu KW, Kim YK, Min JH, et al. Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging. Abdom Radiol (NY). 2017. PMID: 28078380. doi:10.1007/s00261-016-1038-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。